跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 107,155 条关于
“anti-GBM disease”
全部
107,155
临床试验
77,827
药物
5,586
机构
247
资讯
23,495
9个月前
Hansa Biopharma's Phase 3 Trial for Anti-GBM Disease Fails Primary Endpoint Despite Improved Dialysis-Free Outcomes
去年
Hansa Biopharma's Imlifidase Shows Promise in Guillain-Barré Syndrome and Anti-GBM Disease
去年
Imlifidase Shows Promise in Guillain-Barré Syndrome and Expands Gene Therapy Access
去年
AstraZeneca's AZD1390 Enters GBM AGILE Trial for Newly Diagnosed Glioblastoma Patients
去年
AZD1390 to be Evaluated in GBM AGILE Trial for Newly Diagnosed Glioblastoma
去年
Glioblastoma Organoids Accurately Model Patient Response to CAR-T Cell Therapy in Real Time
去年
AZD1390 to be Evaluated in GBM AGILE Trial for Glioblastoma
去年
Purdue Pharma's Tinostamustine Enters Phase 2/3 GBM AGILE Trial for Glioblastoma Treatment
去年
AZD1390 to be Evaluated in GBM AGILE Trial for Newly Diagnosed Glioblastoma
去年
GBM Health Secures $1.5M Grant to Advance AI Diagnostics and Sustainable Biomanufacturing
第 1 页,共 2350 页
上一页
下一页